Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.
Thank you. Please check your inbox to confirm.
U.S. health advisors endorsed a one-dose COVID-19 vaccine from Johnson & Johnson on Friday, putting the nation on the cusp of adding an easier-to-use option to fight the pandemic.
Watch the committee meeting in the video player above.
The Food and Drug Administration is expected to quickly follow the recommendation and make J&J’s shot the third vaccine authorized for emergency use in the U.S.
Vaccinations are picking up speed, but new supplies are urgently needed to stay ahead of a mutating virus that has killed more than 500,000 Americans.
After daylong discussions, the FDA panelists voted unanimously that the benefits of the vaccine outweighed the risks for adults.
READ MORE: 8 tips for finding a COVID-19 vaccine
If the FDA agrees, shipments of a few million doses could begin as early as Monday.
More than 47 million people in the U.S., or 14 percent of the population, have received at least one shot of the two-dose vaccines from Pfizer and Moderna, which FDA authorized in December.
But the pace of vaccinations has been strained by limited supplies and delays due to winter storms.
Support Provided By:
Additional Support Provided By: